Tobin NP - Search Results

1

An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast Tumors.

Tobin NP, Wennmalm K, Lindström LS, Foukakis T, He L, Genové G, Östman A, Landberg G, Betsholtz C, Bergh J. Tobin NP, et al. Clin Cancer Res. 2016 May 15;22(10):2417-26. doi: 10.1158/1078-0432.CCR-15-1691. Epub 2016 Jan 14. Clin Cancer Res. 2016. PMID: 26769751

2

Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features.

Lehn S, Tobin NP, Berglund P, Nilsson K, Sims AH, Jirström K, Härkönen P, Lamb R, Landberg G. Lehn S, et al. Among authors: tobin np. Am J Pathol. 2010 Dec;177(6):2886-97. doi: 10.2353/ajpath.2010.100303. Epub 2010 Oct 22. Am J Pathol. 2010. PMID: 20971731 Free PMC article.

3

Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

Lundgren K, Tobin NP, Lehn S, Stål O, Rydén L, Jirström K, Landberg G. Lundgren K, et al. Among authors: tobin np. J Mol Diagn. 2011 May;13(3):340-51. doi: 10.1016/j.jmoldx.2011.01.009. J Mol Diagn. 2011. PMID: 21497294 Free PMC article.

4

Cyclin D1, Id1 and EMT in breast cancer.

Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G. Tobin NP, et al. BMC Cancer. 2011 Sep 28;11:417. doi: 10.1186/1471-2407-11-417. BMC Cancer. 2011. PMID: 21955753 Free PMC article.

5

Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.

Tobin NP, Lundgren KL, Conway C, Anagnostaki L, Costello S, Landberg G. Tobin NP, et al. Hum Pathol. 2012 Nov;43(11):2053-61. doi: 10.1016/j.humpath.2012.02.015. Epub 2012 May 29. Hum Pathol. 2012. PMID: 22647349

6

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms.

Tobin NP, Bergh J. Tobin NP, et al. Curr Breast Cancer Rep. 2012 Sep;4(3):171-173. doi: 10.1007/s12609-012-0083-7. Epub 2012 Jun 22. Curr Breast Cancer Rep. 2012. PMID: 22924091 Free PMC article.

7

Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling.

Frings O, Augsten M, Tobin NP, Carlson J, Paulsson J, Pena C, Olsson E, Veerla S, Bergh J, Ostman A, Sonnhammer EL. Frings O, et al. Among authors: tobin np. Am J Pathol. 2013 Jun;182(6):2037-47. doi: 10.1016/j.ajpath.2013.02.018. Epub 2013 Apr 10. Am J Pathol. 2013. PMID: 23583284 Free article.

8

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies.

Milosevic J, Klinge J, Borg AL, Foukakis T, Bergh J, Tobin NP. Milosevic J, et al. Among authors: tobin np. BMC Cancer. 2013 Oct 11;13:473. doi: 10.1186/1471-2407-13-473. BMC Cancer. 2013. PMID: 24119434 Free PMC article.

9

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.

Lehn S, Tobin NP, Sims AH, Stål O, Jirström K, Axelson H, Landberg G. Lehn S, et al. Among authors: tobin np. BMC Cancer. 2014 Feb 22;14:119. doi: 10.1186/1471-2407-14-119. BMC Cancer. 2014. PMID: 24559095 Free PMC article. Clinical Trial.

10

Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.

Tobin NP, Lindström LS, Carlson JW, Bjöhle J, Bergh J, Wennmalm K. Tobin NP, et al. Mol Oncol. 2014 May;8(3):741-52. doi: 10.1016/j.molonc.2014.02.007. Epub 2014 Feb 28. Mol Oncol. 2014. PMID: 24630985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters